To access members-only content, you must login or register an account. The Redeye membership is free, but you need to apply via our application form.
Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.
It is important to look beyond the numbers and seek a likely catalysts, which could unlock value, and estimate how long it will take for the catalyst to play out. These events, or Catalyst Potential, reduce risk by narrowing the gap between price and value in a more predictable way. This is particularly important when investing in a low-quality business where time is like a ticking bomb stacked against the company.
Catalyst Potential is a Premium members feature in Redeye Universe.APPLY FOR MEMBERSHIP
Next Earnings Date
Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.
|Relative Price Strength
Relative Price Strength
Relative Strength is defined as the share price performance versus the market index. Stocks with 3 to 12 month relative strength (vs the market) above zero have been shown in many studies to continue their outperformance by several percent over the following year. 1-month relative strength has actually been shown to be less reliable as a predictor (even inversely correlated with subsequent performance) but it is still closely watched. Each indicator is bullish (arrow pointing up highlighted in green) when it is above zero.
|Rel Price Chg 3 Months||-19.6%||
|Rel Price Chg 12 Months||-26.1%|
The big institutional funds cannot trade in and out of a stock without leaving their footprints, and learning to read the signs in daily and weekly volume is important. If current trading volumes are higher than previous volumes while price is increasing, it may be a bullish sign (arrow pointing up highlighted in green) of increasing institutional demand and should be watched carefully. However, volume is an indicator of a trend reversal if it goes in a direction contrary to a prevailing price trend – i.e. the price is higher than the 200-day moving average. The table below provides general rules for volume analysis.
|Avg Vol 10 vs 60 Days||-34.1%|
Momentum trading strategies often involve the buying of stocks that are trading near their 52-week high in the expectation that the stock will continue to reach new highs. Stocks are bullish (arrow pointing up highlighted in green) when they are within 5% of the 52-week high or they achieved a new high (low) within the 5 most recent trading days.
The Moving Average we compare against is the average of the last n days closing prices. Some successful momentum trading strategies buy stocks that are trading above their 50-day and 200-day moving averages, and many investors will not buy stocks that trade below them. These indicators are bullish (arrow pointing up highlighted in green) when a stock is trading positively and above these moving averages. However particular strong indication of bullish sentiment - a golden cross - occurs when a stock's short-term (50-day) moving average rises above its long-term (200-day) moving average. And vice versa - a death cross - when the short-term moving average falls below the long-term moving average.
|50-Day Moving Average||-2.1%|
|200-Day Moving Average||-3.2%|
Last price: 32.10 SEK
|Prev Close||[[ prevClose|number:2 ]] SEK||Change||[[ changeValue|number:2 ]] %|
|High||[[ highValue|number:2 ]] SEK||Avg Daily Volume||[[ avgVolume|number:0 ]] Shares|
|Low||[[ lowValue|number:2 ]] SEK||Avg Daily Turnover||[[ graphAvgTurnover|number:2 ]] SEK|
|Per Norlén, CEO|
|Per-Olof Schrewelius, CFO|
|Peter Benson, Chairman of the board|
Last updated: 2017-02-13 Source: Redeye
|Banque Internationale à Luxembourg SA||18.1%||18.1%|
|Johnson & Johnson Innovation||8.2%||8.2%|
|Sunstone Life Science Ventures||8.2%||8.2%|
|Duba AB (Investor)||7.0%||7.0%|
|Atlas Antibodies AB||3.7%||3.7%|
|JP MORGAN Bank Luxembourg||2.6%||2.6%|
Last updated: 2017-02-13 Source: Redeye
Total insider purchases and sales reported
|Last 12 Weeks||
|Last 24 Weeks||
Thank you for becoming a member.
We just sent an email to your registered email address. Please click on the link in the email to activate your Redeye membership.
You need to activate your membership within 12 hours.
Redeye Member Service
By clicking "Sign up" you indicate that you read and agree to our Terms & ConditionsI already have an account and want to sign in